Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

Olivier Bernard, a Quebec pharmacist and blogger shown in this undated handout photo, has won a prestigious international prize for standing up for science.

The Canadian Press

A Quebec pharmacist and blogger who takes on junk science with cartoons, a sense of fun and a no-nonsense attitude has won a prestigious international prize for science communication.

Olivier Bernard, also known as “The Pharmafist,” was awarded the John Maddox Prize on Tuesday for his work in debunking myths around the use of vitamin C to treat cancer.

“It’s important to defend science, to stand up to those kind of threats,” Mr. Bernard said from London, where he was picking up the award given by the journal Nature and the group Sense About Science.

Story continues below advertisement

Mr. Bernard, 38, has done pharmaceutical research and has been a working pharmacist since 2004. It was that experience that pushed him into science communication.

“I had so much frustration working at the pharmacy and seeing all those beliefs that people held about health, about science. Things that we know in the scientific community that are not true, I saw on a daily basis.

“It’s really hard when you have to deconstruct those beliefs in order to help people. I thought, is there any way I could do this on a bigger scale?”

In 2012, he started a blog called “The Pharmafist: Bringing life to science and death to pseudo-science.”

The blog presents straight-up medical research and interviews with international experts in a cheeky format replete with cartoons. It doesn’t dodge big targets and has done episodes on osteopathy and homeopathy (“I can’t believe we sell homeopathy in pharmacies,” he said). The blog grew into a TV show called Adventures of a Pharmacist.

The lighthearted attitude helps, Mr. Bernard said.

“People could feel attacked. But there is a way you can give people the information without telling them they’re stupid or making them feel stupid.”

Story continues below advertisement

That didn’t prevent last year’s fight over an ostensible cancer treatment involving the injection of large doses of vitamin C. Although that’s an approved treatment for scurvy, the cancer aspect is not recognized in either the United States or Canada.

Petitions with at least 65,000 signatures were demanding Quebec approve vitamin C for use by cancer patients. The issue was discussed on popular TV shows and was championed in the National Assembly.

Mr. Bernard looked into it.

“Pretty much everything was wrong in the petition.”

Research was scanty and poorly designed. The injections themselves were not risk-free. He published what he’d learned.

For months, his site and his Facebook feed were full of insults, but “that was OK,” Mr. Bernard said.

Story continues below advertisement

Then, he called out the politician who supported the petition.

“All hell broke loose. They decided to just crush me.”

He got death threats. His place of work was publicized and his employer was asked to fire him. His wife, an author, faced a boycott of her books. There were demands to cancel his TV show and his professional accreditation.

Finally, Mr. Bernard wrote a Facebook post laying out what was happening. The harassment stopped, but better still was the support from Quebec’s science and medical community.

“There was a massive outcry. Specialists, oncologists, professional associations – they all came forward.”

The petition was rejected.

Story continues below advertisement

“It created all this wave of positive things. Now I’m back to what I do.”

Science communication has never been harder, Mr. Bernard said.

“It’s very challenging for people. Most information about science online is, at best, incomplete and, at worst, completely false.

“That’s the case in climate change. That’s the case in medicine. People want to have information, but they don’t know how to differentiate between the good and the bad. And then at the end of the day, they go with their gut feeling.

“I don’t like it when people are being manipulated.”

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Follow related topics

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies